Patent · US Active

Pyruvate kinase activators for use in therapy

US9980961B2 · kind B2 · utility

8Cited by
132References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 1, 2017
Grant dateMay 29, 2018
Priority date—
Expiry dateMay 1, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.